Technology | 2022.03.30
DSM Biomedical and Svelte Medical Systems Partner to Develop DISCREET Bioresorbable Coating Technology Used with SLENDER IDS® and DIRECT RX® DES Systems
Through a long-term strategic partnership, DSM Biomedical, the world’s unrivaled biomaterials expert and committed partner in driving sustainable innovation in healthcare, and Svelte Medical Systems, a privately-held company engaged in the development of highly deliverable balloon expandable stents, have revolutionized the standard for coronary stenting procedures to treat coronary artery disease (CAD).
(PRWeb March 30, 2022)
Read the full story at https://www.prweb.com/releases/2022/3/prweb18587029.htm
For more information, please visit
https://www.prweb.com/releases/2022/3/prweb18587029.htm
